Natural extracts of Astragali radix, cycloastragenol and calycosinvia FXR activation attenuates triglyceride accumulation and hepatic fibrosis in NAFLD animal models [114,115]. This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatotic liver disease.